NCT04457180 2022-10-26A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor SubjectsJiangsu HengRui Medicine Co., Ltd.Phase 1 Completed18 enrolled